A method is described for preparing a plasma-membrane fraction from hepatocytes by a rapid, gentle, Percoll fractionation procedure. Cholera toxin elicited the ribosylation of a number of proteins in these membranes, including the components of the stimulatory guanine nucleotide regulatory protein, N, Insulin, however, inhibited the ability of cholera toxin to ribosylate a protein of Mr 25 000. The action was decreased in membranes from cells that had been pre-treated with glucagon.
Insulin binds to specific receptors embedded within the cell plasma membrane. These are responsible for triggering a variety of responses within the cell. Although the receptors have been shown to exhibit a tyrosine kinase activity, the molecular mechanism whereby occupied insulin receptors elicit their effects has yet to be defined (Houslay, 1984b (Houslay, , 1985 Abbreviations used: SDS, sodium dodecyl sulphate; TPA, 12-0-tetradecanoylphorbol 13-acetate. ¶ To whom reprint requests should be sent, at the Glasgow address.
1983; Denton et al., 1981) . Indeed, it has been suggested that multiple signalling mechanisms may exist .
Insulin has, however, been demonstrated both to inhibit glucagon-stimulated adenylate cyclase activity and to activate a peripheral liver plasma-membrane cyclic AMP phosphodiesterase (Marchmont & Houslay, 1980; Houslay et al., , 1984 Heyworth et al., 1983a,b) both in intact hepatocytes and in broken membranes. These particular actions of insulin appear to be dependent on GTP, and it has been suggested that a unique guanine nucleotide regulaVol. 228 tory protein, Nin, is responsible for mediating these effects of insulin  Houslay .
Many hormones exert their effects by altering the intracellular concentrations of cyclic AMP. They appear to do this by either activating or inhibiting adenylate cyclase (Ross & Gilman, 1980; Houslay, 1983 Houslay, , 1984a . This is achieved by the occupied hormone receptors interacting with specific species of guanine nucleotide regulatory proteins. Thus stimulatory effects are mediated through N, (Northup et al., 1983a,b; Hildebrandt et al., 1983) and inhibitory effects through Ni (Katada & Ui, 1979 , 1981 Northup et al., 1983b) . Another guanine nucleotide regulatory protein, called transducin, has also been identified. This is responsible for mediating the rhodopsin-catalysed photoactivation of a cyclic GMP phosphodiesterase (Yamazaki et al., 1983; Fung, 1983; Van Dop et al., 1984) . The identification of these distinct guanine nucleotide regulatory proteins has been greatly aided by specific toxins which catalyse the NAD+-dependent ADP-ribosylation of these proteins. Thus cholera toxin ribosylates and activates both N, (Cassel & Pfeuffer, 1978) and transducin (Abood et al., 1982) , whereas pertussis toxin (isletactivating protein) ribosylates and inhibits the functioning of both N1 (Katada & Ui, 1981; Hildebrandt et al., 1983; Northup et al., 1983b) and transducin (Van Dop et al., 1984) . These guanine nucleotide regulatory proteins all appear to be part of a family, as they consist of distinct species of asubunits, which provide the site for ADP-ribosylation, and a common type of fl-subunit (Manning & Gilman, 1983) . These guanine nucleotide regulatory proteins are activated by interaction with the occupied receptor (or photoactivated rhodopsin), leading to a conformational change in the asubunit, leading to its activation and dissociation from the fl-subunit (Codina et al., 1984b) .
The putative Nin also appears to be acted on by cholera toxin. Evidence for this comes from the observation that cholera toxin activates the peripheral phosphodiesterase and prevents insulin inhibiting adenylate cyclase , presumably by having activated Nin. Cholera toxin also obliterates insulin's GTP-dependent stimulatory effect on a cyclic AMP-independent protein kinase in sarcolemma membranes (Walaas et al., 1981) . Unlike pertussis toxin, which only ribosylates a single protein species in hepatocytes (Heyworth et al., 1984a) and other cell membranes (Katada et al., 1982; Hanski & Gilman, 1982; Codina et al., 1983; Bokoch et al., 1983) , cholera toxin catalyses the ribosylation of a number of plasma-membrane proteins (Cooper et al., 1981; Gill, 1982) . This suggests that there may be a family of guanine nucleotide regulatory proteins. In this study we show that insulin inhibits the cholera-toxin-catalysed ribosylation of a single protein species of Mr 25000. The properties of this action of insulin are consistent with this target protein being the putative Nin that we Houslay et al., 1984) have previously suggested mediates certain of the actions of insulin.
Materials and methods
Hepatocyte plasma membranes were prepared from male 200-250g Sprague-Dawley rats by a modification of the gentle disruption and Percoll fractionation procedure developed by us previously . Preparation of Percoll gradient A stock Percoll solution was made as a 90%O (v/v) suspension in 0.25M-sucrose immediately before use. This stock solution was diluted to give final concentrations of 0.25 M-sucrose, 3 mM-imidazole and 15% (v/v) Percoll with respect to the 90% (v/v) stock Percoll solution. The pH of this suspension was adjusted to pH 7.4 with dilute HCl. The Percoll gradient was prepared by placing 30ml of this solution in 50ml centrifugation tubes and layering 2ml of 0.25M-sucrose/3mM-imidazole, pH7.4, on top.
Preparation of hepatocytes
Hepatocytes were prepared from male SpragueDawley rats (225-250g body wt.) as described by Elliott et al. (1976) . After the last wash with KrebsHenseleit (1932) buffer, the cells (Ig dry wt.) were washed finally with 0.25 M-sucrose/3 mM-imidazole, pH7.4 (80ml), and sedimented in a MSE Minor bench centrifuge, at 500g,,*. for 2.5min.
This and all further procedures were carried out at 40C.
Homogenization of hepatocytes
The cells (1 g dry wt.) were resuspended in 0.25M-sucrose/3 mM-imidazole, pH 7.4 (40 ml), and placed in a 50ml Amicon ultrafiltration device, which had the bottom filter plates removed and the gas outlet sealed with a gate clip. These cells were incubated for 10min under N2 (151b/in2). This system was depressurized rapidly by releasing the gate clip and allowing the cell suspension to be collected, through the bottom outlet valve of the Amicon ultrafiltration device, in a Camlab glass homogenization vessel (50ml capacity). With a Teflon pestle, the cells were homogenized with two gentle up-and-down strokes immediately after nitrogen cavitation (depressurization). This suspension was centrifuged at 500gma,. for 2.5 min.
The supernatant was collected, and the pellet was resuspended in 0.25 M-sucrose/3 mM-imidazole, pH7.4 (20ml), and the whole of the above pressurization, depressurization and homogenization procedure was repeated once. care was taken to resuspend pellets by gentle agitation. They were never vortex-mixed. The loose pellet was stored in batches at -800C until used. These batches were never used again after thawing.
Preparation of a crude washed plasma-membrane fraction
From cells which had been pre-treated with various agents, a crude washed plasma-membrane fraction was obtained as described in detail previously (Houslay & Elliott, 1979 , 1981 . In studies with these membranes and those prepared as above, essentially similar results were obtained. (Pfeuffer, 1977) as described previously for liver plasma membranes (Wong & Martin, 1983) . 32P-labelled GTP-y-azidoanilide was synthesized from [y-32P]GTP prepared by the method of Johnson & Walseth (1979) and used to photolabel plasma membranes as described by Wong & Martin (1983) . Guanosine 5'-[y-thio]triphosphate (250pM) was used to identify high-affinity GTPbinding sites by inhibiting their labelling with GTP-y-azidoanilide (Wong & Martin, 1983; Pfeuffer, 1977) .
Insulin analysis 1251-labelled bovine insulin (1 nM) was incubated at 30°C for I 0 min in 100 mM-potassium phosphate buffer, pH7.5, containing 6mM-dithiothreitol. It was then either subjected to h.p.l.c. analysis or insulin radioimmunoassay analysis. H.p.l.c. was carried out on an LKB system with a reverse-phase column (Lichrosorb RP-18, 54uM) with isocratic elution with 0.1 M-NaH2PO4/H3PO4, pH3.1, 0.1% triethylamine and 36% acetonitrile. This allowed for the separation of insulin, its a-chain and its bchain with retention times of approx. 5.5, 4.5 and Vol. 228 6.5min respectively at a flow rate of 0.5ml/min. Radioactivity was assessed by y-emission. Insulin radioimmunoassay was performed in the clinical routine laboratory of the Department of Clinical Biochemistry, Royal Infirmary, Glasgow. In this assay, using a polyclonal anti-insulin antibody, the isolated a-and b-chains expressed 0.016% and 0.025% of the reactivity compared with native insulin (I100%).
From both of these approaches it was shown that insulin did not (< 5%) dissociate into its constituent chains under the assay conditions described.
Cholera toxin, pig and bovine insulin, bovine serum albumin, thymidine, TPA, snake venom phosphodiesterase (EC 3.1.4.1; Crotalus atrox) and alkaline phosphatase (EC 3.1.3.1; Escherichia coli) were from Sigma (London) Chemical Co., Poole, Dorset, U.K. Glaxo compound no. 117 (see Tait & Nassau, 1984) 
Results
Hepatocyte plasma membranes were isolated by a modification of the rapid, gentle, Percoll fractionation procedure developed by us previously . The marker enzyme distribution for these is shown in Table 1 . The plasma-membrane markers, leucine aminopeptidase (Peters et al., 1972) and 5'-nucleotidase (Gurd & Evans, 1974; Reimer & Widnell, 1975) , showed a pronounced purification over the homogenate. This fraction appeared to be relatively free of contamination from endoplasmic reticulum, mitochondria and lysosomes, as indicated by glucose-6-phosphatase, succinate dehydrogenase and acid ,Bgalactosidase activities respectively. This fraction does, however, show contamination with Golgi, as indicated by the results with galactosyltransferase. This method provides a rapid, gentle, means of preparing a fraction enriched in plasma membranes.
Plasma (Houslay & Elliott, 1979 , 1981 did not alter the pattern of labelling obtained and, indeed, no labelling was observed in the absence of cholera toxin (Fig. 1) . We also found (results not shown, but see also Figs. 3 and 6) that similar labelling patterns were obtained by using either these purified plasma membranes or a crude plasma-membrane fraction prepared as described previously (Houslay & Elliott, 1979 , 1981 . There are two major labelled bands, of Mr 42 000 and 45000 (Fig. 1) , where cholera-toxin-mediated ribosylation was enhanced by GTP. (Pfeuffer et al., 1983) or liver (Kahn & Gilman, 1984; Codina et al., 1984a) . Others (Malbon & Greenberg, 1982; Cooper et al., 1981) have noted that two bands, of Mr 42000 and Mr 45000, appear to form the major cholera-toxin substrates in rat liver plasma membranes, although Doberska et al. (1980) noted only a Mr-42000 component. In the present study we observed the labelling of both the Mr-42000 and Mr-45000 species, although the intensity of labelling of the Mr-45000 species appeared to vary somewhat between experiments. Certainly, over this period of incubation with cholera toxin the adenylate cyclase activity has become fully activated (Martin et al., 1977 ; C. M. Heyworth & M. D. Houslay, unpublished work). Our data (Fig. 1) also confirm other studies (Doberska et al., 1980; Cooper et al., 1981; Malbon & Greenberg, 1982) that purified liver plasma membranes contain a number of targets for cholera-toxin-catalysed ADP-ribosylation, other than just the components of Ns. One clearly resolved target, whose labelling by cholera toxin and [32P]NAD+ shows a marked GTP-dependent effect, has Mr 25000. Under the conditions used, labelling of the Mr-25 000, -42000 and -45 000 bands were maximal after 15min incubation with pre-activated cholera toxin (125 Mg/ml). (In the studies described here, incubations were carried out for 10min at 30°C.)
We note here ( Fig. 1 ; Table 2 ) that, if insulin (1 nM) was included in the ribosylation assay together with GTP (0.1 mM), the labelling of the Mr-25000 subunit was inhibited. This effect of insulin occurred at half-maximal concentrations of 0.1-0.5 nM (range, n = 2). We also observed that, when high concentrations of insulin (greater than 10nM) were used, the ability of insulin to block the cholera-toxin-mediated labelling of the Mr-25 000 species was lost. Similarly, high concentrations of insulin (> 10nM) have also been shown to lead to a loss in the ability of insulin to activate cyclic AMP phosphodiesterase (Elks et al., 1983) and to inhibit adenylate cyclase (C. M. Heyworth & M. D. Houslay, unpublished work). Insulin did not, however, affect the degree of labelling of the Mr-42000 and -45000 bands (Table 2) . If glucagon, rather than insulin, was included in the ribosylation mixture, no effect on the labelling of the Mr-25 000 band was observed. However, we noted that glucagon, unlike insulin, allowed a small increase in the labelling of the Mr-42 000 and -45 000 bands during the experiment (Table 2) .
Photoaffinity labelling of the purified plasma membranes with [32P]GTP-azidoanilide allowed Table 2 . Cholera-toxin-catalysed labelling ofplasma-membrane proteins Results are expressed as means + S.D. for n experiments using different cell preparations; data obtained for partially purified or purified plasma-membrane preparations are combined. Hormones were added to the ribosylation mixture as described in detail in the Materials and methods section. The degree of labelling was quantified by densitometric analysis of autoradiographs. In each instance comparison was made with appropriate controls with hormone present. All labelling reactions were performed in the presence of GTP (0.1 mM).
Labelling (% of control)
Hormone added n Band (Mi)-..
Insulin (1 nM)
Glucagon (I nM) * Range 37-71% of control. several labelled species to be identified after SDS/polyacrylamide-gel electrophoresis and autoradiography (Fig. 2) . The addition of guanosine 5'-[y-thio]triphosphate (250iM) to the photolabelling assays decreased the labelling of these species, indicating that these might exhibit high-affinity GTP-binding sites (Fig. 2 ). There were differences in the degree of effectiveness of guanosine 5'-[ythio]triphosphate as regards particular bands (Fig.   2 ), no doubt reflecting the different affinities of these species for both GTP and guanosine 5'-[ythio]triphosphate, as has been shown for N, and Ni (see Hildebrandt et al., 1982) . In particular, we noted that a component of M, 25000 was labelled (Fig. 1) . This presumed high-affinity GTP-binding protein co-migrated with the insulin-sensitive ribosylated component, of the same Mr, when run on the same gel.
If intact hepatocytes are preincubated with cholera toxin (1 ,g/ml) for 45min at 370C, it is known that adenylate cyclase has already become fully activated after 30min incubation (Houslay & Elliott, 1979 , 1981 . When membranes from hepatocytes treated in such a fashion were incubated in the ribosylation assay, no labelling of the Mr-25 000 band was seen and labelling of the Mr-42 000 and -45 000 components of N, was decreased markedly (Fig. 3) . Pre-treatment of the intact cells with islet-activating protein (pertussis toxin) at 1 OOng/ml for 1 h, however, actually enhanced the ability of cholera toxin to ribosylate the components (Mr-42000 and -45000 bands) of Ns, in isolated membranes under the conditions specified (Fig. 3) . It did not, however, enhance the ability of cholera toxin to ribosylate the Mr-25000 species. Indeed, the labelling of this species by cholera toxin was decreased by about 19-33%.
When thiol-pre-activated pertussis toxin was used to label plasma membranes (Fig. 3) with [32P]NAD+, a major ribosylated band of Mr40000 was observed (Heyworth et al., 1984a) . The labelling of this band appeared to be enhanced in cells that had been pre-treated with cholera toxin, and decreased in those pre-treated with pertussis toxin (Fig. 3) .
Glaxo compound no. 117 inhibits the ability of cholera toxin both to elicit NAD+-dependent ADP-ribosylation and to activate adenylate cyclase (Coulson et al.,-1983; Tait & Nassau, 1984) . When the ribosylation inhibitor compound 117 (0.5 mM) was added to the ribosylation assays containing GTP (0.1 mM), the cholera-toxininduced labelling of the Mr-25000, -42000 and -45000 protein species was inhibited (Fig. 4) . This provides further support to the contention that the labelling of these bands reflects their ADPribosylation by cholera toxin. If hepatocytes were preincubated for 5 min with insulin (1 nM) at 30°C, before preparation of membranes for use in the ribosylation assay, we observed that cholera toxin still affected the ribosylation of the Mr-25 000 species. Furthermore, when insulin (1 nM) was added to the ribosylation assay containing such pre-treated membranes, the addition of insulin to the membrane ribosylation assay still led to the inhibition of the ribosylation of the Mr-25 000 component (results not shown). However, if the hepatocytes were pre-treated for 5min with glucagon (lOnM) at 37°C, before preparation of membranes, then, although choleratoxin treatment of the isolated membranes led to the ribosylation of the Mr-25 000 species (Fig. 5) , such a pre-treatment decreased the ability of insulin (1 nM) to inhibit the cholera-toxin-mediated ribosylation of this species in isolated membranes (Fig. 5) . In such instances insulin decreased the labelling of the Mr-25000 band to 75-106% of the control (GTP + cholera toxin; given as range for three separate experiments).
In membranes from hepatocytes pre-treated for 15min at 37°C with TPA (lOng/ml), cholera toxin failed to label the Mr-25 000 band, even though labelling of the Mr-42 000 and -45 000 bands ensued (Fig. 6) , with a similar intensity to that of control cells. However, if insulin (1 nM) was added to the ribosylation mixture, cholera toxin then appeared able to elicit the labelling of the Mr-25 000 band. The presence of insulin did not affect the degree of labelling of any other band (Fig. 6 ).
The M,-25 000 band appeared to be localized in the plasma-membrane fraction, as it was not observed when various other subcellular membrane fractions from a Percoll fractionation of the cell homogenate were treated with [32P]NAD+ and cholera toxin (results not shown).
Discussion
Cholera toxin not only activates adenylate cyclase in whole cells (see Gill, 1982; Houslay & Elliott, 1979 , 1981 but will also elicit activation in broken membranes if it is first pre-activated by exposure to thiol reagents (Johnson & Bourne, 1977; Gill, 1977) and then incubated with the Vol. 228 :Ami
membranes together with NAD+ and GTP. It elicits this activation by triggering the ADPribosylation of the a-subunit(s) of N, (Cassel & Pfeuffer, 1978) , Mr-42000 and for Mr 45000 (Pfeuffer et al., 1983; Kahn & Gilman, 1984; Codina et al., 1984a) . In purified liver (Doberska et al., 1980; Cooper et al., 1981; Malbon & Greenberg, 1982; Gordon &°B lecher, 1984) and other (Cooper et al., 1981) 0 plasma membranes a number of proteins can be ADP-ribosylated by cholera toxin in an NAD+-dependent fashion. In the present study we confirm those observations and show that the effects are enhanced by GTP (Fig. 1) . u
The enhanced labelling by cholera toxin of the components of N, which we observed in membranes from pertussis-toxin pre-treated cells, might offer a molecular explanation for the observations by Hsia et al. (1984) , who noted that such a pretreatment enhanced the ability of cholera toxin to activate adenylate cyclase. We also demonstrate here that a number of proteins that are ADPribosylated by cholera toxin co-migrate with species that apparently exhibit specific GTPbinding sites as identified by their labelling with azido-GTP (Fig. 2) .
We have proposed that insulin exerts certain of (e) its actions through a specific species of guanine nucleotide regulatory protein called Nn, which should be a substrate for the action of cholera toxin Houslay et al., 1984) .
The activation of Ns by cholera toxin and guanine nucleotides causes the dissociation of the Ns complex to yield the free fl-subunit and an activated a-subunit (see Houslay, 1984a , for review). The conformation of the released activated a-subunit has been shown (Hudson et al., 1981) to differ from the inactive a-subunit, which is complexed with the fl-subunit (Ns complex). So far, (c) all of the guanine nucleotide regulatory proteins investigated to date have a similar structure, with an a-(GTP-binding) subunit which dissociates from a (common) fl-subunit (Manning & Gilman, (b.) Fig (Fig. 5) . This is consistent with our observations that glucagon pre-treatment of hepatocytes obliterated the ability of insulin both to activate the peripheral cyclic AMP phosphodiesterase and to inhibit hormone-stimulated adenylate cyclase ). There we suggested that treatment of intact hepatocytes with glucagon led to a modification of Nin which prevented its activation by insulin. The nature of this cyclic-AMP-independent modification remains to be determined. TPA is a potent tumour-promoting agent (Weinstein et al., 1978 ), which appears to be able to activate protein kinase C (Nishizuka, 1983) and can also enhance tyrosine phosphorylation in intact cells (Gilmore & Martin, 1983; Grunberger et al., 1984) , including that of the insulin receptor (Jacobs et al., 1983) in intact cells. Here we see that, in membranes from cells pre-treated with TPA, cholera toxin then failed to elicit the ribosylation of the Mr-25 000 protein (Fig. 6 ). Indeed, with such membranes, insulin now actually allowed cholera toxin to ribosylate this Mr-25 000 species (Fig. 6) . Clearly, in the present, as in all of these ribosylation studies, we can make no functional extrapolations from the degree, or not, of labelling that occurred. However, phorbol esters exert insulin-like actions in stimulating both lipogenesis (van de Werve et al., 1985) and lactate production (Brown et al., 1979) , as well as inhibiting glucagon-stimulated adenylate cyclase at its point of regulation by guanine nucleotide (Heyworth et al., 1984b) . They also modulate the stimulatory effects of submaximal insulin concentrations on lipolysis (van de Werve et al., 1985) , implying that insulin and TPA can exert actions on a common target, perhaps Ni. The changes that are elicited nevertheless provide a strong indication for functional interactions between components, in particular the possibility that the insulin receptor interacts with a species of M, 25000, tentatively identified as Nin
The epidermal-growth-factor receptor, which bears many similarities to that for insulin (see Houslay, 1981 Houslay, , 1984b , has been shown to interact with H-ras-p21, the oncogene product of Harvey murine sarcoma virus (Kamata & Feramisco, 1984) . Preliminary experiments by the same authors have indicated that this is also true of the insulin receptor (Kamata & Feramisco, 1984) . This oncogenic product, of Mr 21000-24000, associates with the plasma membrane and exhibits a highaffinity GTP-binding site (Cooper & Lane, 1984; McGrath et al., 1984; Shih et al., 1980; Willingham et al., 1980) . It is possible that Nin may be a cellular variant of p21 or a related protein, as a cellular homologue of viral p21 is expressed in small amounts in normal cells (Langbeheim et al., 1980; Cooper & Lane, 1984) . Njn might thus have importance in regulating a number of cellular processes, including exerting an influence on cell growth control (see .
At a minimum, our results suggest that the insulin receptor interacts with the guanine nucleotide regulatory system in liver plasma membranes. The resolution and reconstitution of the putative Ni, with the insulin receptor and other components is now required.
